Press release
Deadline on Feb. 8th coming up in Lawsuit for Investors in shares of Organogenesis Holdings Inc. (NASDAQ: ORGO)
A Deadline is coming up on February 8, 2022in the lawsuit for certain investors in Organogenesis Holdings Inc. (NASDAQ: ORGO).
Investors who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and there are strict and short deadlines running. Deadline: February 8, 2022. NASDAQ: ORGO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Organogenesis Holdings Inc. (NASDAQ: ORGO) common shares between March 17, 2021 and October 11, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 17, 2021 and October 11, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products, that the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements, that as a result of all the foregoing, the Company’s revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.
Those who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Feb. 8th coming up in Lawsuit for Investors in shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) here
News-ID: 2538562 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Organogenesis
Skin Grafts Market Is Booming Worldwide 2025-2032 | Organogenesis, Integra LifeS …
Global skin grafts market is estimated to be valued at USD 1.12 Bn in 2025 and is expected to reach USD 1.85 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
According to the latest research by Coherent Market Insights, the Skin Grafts Market is projected to witness significant growth from 2025 to 2032. This report provides a detailed outlook on market trends, drivers,…
Amniotic Product Market Massive Growth opportunity Ahead | MiMedx, Smith & Nephe …
Exactitude Consultancy has recently released a comprehensive research report titled "Amniotic Product Market Insights, Extending to 2032." This publication spans over 110+ pages and offers an engaging presentation with visually appealing tables and charts that are self-explanatory.
The extensive Amniotic Product market report conducts market research to assist clients in predicting investment in a growing market, expanding their market share, or achieving success with a new product. Various insights about the…
Wound Care Biologics Market Growing Massively by Smith and Nephew, Organogenesis …
"Wound Care Biologics Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors.
The global Wound Care Biologics Market is expected to grow at a significant CAGR of ~5% by 2027.
Biologic wound healing therapies are those that are intended to facilitate the re-establishment of…
Investigation announced for Long-Term Investors in Organogenesis Holdings Inc. ( …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Organogenesis Holdings Inc..
Investors who are current long term investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ORGO stocks follows a lawsuit filed against Organogenesis…
Lawsuit filed for Investors in shares of Organogenesis Holdings Inc. (NASDAQ: OR …
An investor, who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO), filed a lawsuit over alleged violations of Federal Securities Laws by Organogenesis Holdings Inc.
Investors who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and for certain investors are short and strict deadlines running. Deadline: February 8, 2022. NASDAQ: ORGO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Canton, MA based Organogenesis…
Wound Care Biologics Market Analysis Report 2021 | Smith & Nephew, Organogenesis
The Latest research study released by CMI "Global Wound Care Biologics Market" with 360+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. This report likewise contemplates the worldwide Wound Care Biologics market…
